Founded in 2018, TamRx is advancing discoveries made by researchers at Rutgers, The State University of New Jersey. Our scientific founders have developed a novel family of small molecule pan-TAM inhibitors that block tumor growth and stimulate the immune system to fight cancer. The TamRx team is developing a pipeline of products for the treatment of various forms of cancers.
Learn more about our novel cancer technology.
Find out about development partners.
Get to know our drug development team.